China Literature Limited (Stock Code: 772) announced amended Terms of Reference for its Nomination Committee, initially established in October 2017, with the latest revision dated 4 December 2025.

The Committee’s primary function is to identify and recommend appropriate candidates for directorship, oversee the Board’s performance evaluation process, and develop guidelines in line with regulations and listing standards. The newly amended version highlights that the majority of Committee members must be independent non-executive directors, and at least one member should be of a different gender. The chair of the Committee must be either the chairman of the Board or an independent non-executive director.

According to the amended terms, the Committee is required to convene at least once annually, with additional sessions as necessary. Decisions are made by majority vote, and the resources needed to carry out its duties are to be provided by the company. In addition, clear procedures for selecting and assessing director candidates are set out, focusing on skills diversity, experience, and independence in compliance with relevant regulatory requirements.

The document also stipulates clear reporting pathways for Committee decisions, which must be communicated to the Board subject to legal and regulatory requirements. The updated guidelines are intended to strengthen the nomination process, promote diversity and independence, and ensure the Board’s overall effectiveness and governance standards.